Tülay Kuş

648 total citations
47 papers, 416 citations indexed

About

Tülay Kuş is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tülay Kuş has authored 47 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Tülay Kuş's work include Cardiovascular Syncope and Autonomic Disorders (6 papers), Peptidase Inhibition and Analysis (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Tülay Kuş is often cited by papers focused on Cardiovascular Syncope and Autonomic Disorders (6 papers), Peptidase Inhibition and Analysis (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Tülay Kuş collaborates with scholars based in Türkiye, Canada and Cyprus. Tülay Kuş's co-authors include Gökmen Aktaş, Celaletdin Camcı, Mehmet Kalender, Alper Sevinç, Seval Kul, Ertan Şahin, Umut Elboğa, Benan Kılbaş, Y. Zeki Çelen and Havva Yeşil Çınkır and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Tülay Kuş

41 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tülay Kuş Türkiye 12 260 133 77 73 66 47 416
Gökmen Aktaş Türkiye 11 247 0.9× 96 0.7× 68 0.9× 68 0.9× 66 1.0× 37 406
Afonso Celso Pinto Nazário Brazil 14 180 0.7× 94 0.7× 114 1.5× 43 0.6× 54 0.8× 59 434
Marià Carulla Spain 12 229 0.9× 64 0.5× 59 0.8× 95 1.3× 38 0.6× 29 490
M. Bergaglio Italy 12 223 0.9× 42 0.3× 72 0.9× 82 1.1× 16 0.2× 18 396
Siyuan Wang China 12 131 0.5× 105 0.8× 177 2.3× 108 1.5× 30 0.5× 42 545
S Matthes United States 10 207 0.8× 43 0.3× 77 1.0× 97 1.3× 57 0.9× 16 382
A. Wischnik Germany 10 196 0.8× 105 0.8× 108 1.4× 85 1.2× 27 0.4× 59 451
Christian Focan Belgium 8 323 1.2× 57 0.4× 73 0.9× 130 1.8× 35 0.5× 10 535
Chris A. Rhoades United States 11 256 1.0× 111 0.8× 78 1.0× 118 1.6× 14 0.2× 18 505
Mark Peter United Kingdom 10 185 0.7× 150 1.1× 68 0.9× 64 0.9× 41 0.6× 19 524

Countries citing papers authored by Tülay Kuş

Since Specialization
Citations

This map shows the geographic impact of Tülay Kuş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tülay Kuş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tülay Kuş more than expected).

Fields of papers citing papers by Tülay Kuş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tülay Kuş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tülay Kuş. The network helps show where Tülay Kuş may publish in the future.

Co-authorship network of co-authors of Tülay Kuş

This figure shows the co-authorship network connecting the top 25 collaborators of Tülay Kuş. A scholar is included among the top collaborators of Tülay Kuş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tülay Kuş. Tülay Kuş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuş, Tülay, et al.. (2025). Development of a preoperative nomogram to identify low-risk early-stage breast cancer patients eligible for SLNB omission. World Journal of Surgical Oncology. 23(1). 268–268.
2.
3.
Şahin, Ertan, et al.. (2024). 68Ga-FAPI PET/CT as an Alternative to18F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma. Journal of Nuclear Medicine. 65(4). 512–519. 22 indexed citations
4.
5.
Kuş, Tülay, Gökmen Aktaş, & İrfan Çiçin. (2023). Is the “P-value” Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?. The Oncologist. 29(3). 190–191. 1 indexed citations
6.
Kuş, Tülay, et al.. (2022). The predictive value of vitamin D follow-up and supplementation on recurrence in patients with colorectal cancer. Future Oncology. 18(18). 2247–2256. 1 indexed citations
7.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2022). Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement. Molecular Imaging and Biology. 24(5). 789–797. 30 indexed citations
8.
İşbilen, Elif, et al.. (2021). Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors. Turkish Journal of Biochemistry. 46(5). 509–516. 2 indexed citations
9.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2021). Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Annals of Nuclear Medicine. 35(12). 1321–1331. 72 indexed citations
10.
Kuş, Tülay, Fatih Köse, Gökmen Aktaş, et al.. (2020). Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study. Journal of Gastrointestinal Cancer. 52(2). 634–642. 10 indexed citations
11.
Kuş, Tülay, et al.. (2018). Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Kuş, Tülay & Gökmen Aktaş. (2017). Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival. SHILAP Revista de lepidopterología. 43(3). 273–278. 4 indexed citations
13.
14.
Kuş, Tülay, et al.. (2016). Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Bülbül, Feridun, et al.. (2016). Awareness of cancer diagnosis in Turkish patients can increase anxiety and depression: is it true?. Annals of Oncology. 27. vi520–vi520. 1 indexed citations
16.
17.
Kuş, Tülay, et al.. (2016). Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review. Oncology Letters. 11(4). 2801–2805. 11 indexed citations
18.
Süner, Ali, Hakan Büyükhatipoğlu, Gökmen Aktaş, et al.. (2016). Polymorphisms in the <em>MTHFR</em> gene are associated with recurrence risk in lymph node-positive breast cancer patients. OncoTargets and Therapy. Volume 9. 5603–5609. 1 indexed citations
19.
Kuş, Tülay, Gökmen Aktaş, Gökay Alpak, et al.. (2015). Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study. Supportive Care in Cancer. 24(5). 2085–2091. 17 indexed citations
20.
Kuş, Tülay, Gökmen Aktaş, Mehmet Kalender, et al.. (2015). Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib. OncoTargets and Therapy. 8. 3749–3749. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gökmen Aktaş Breakdown of academic impact, for papers by Afonso Celso Pinto Nazário Breakdown of academic impact, for papers by Marià Carulla Breakdown of academic impact, for papers by M. Bergaglio Breakdown of academic impact, for papers by Siyuan Wang Breakdown of academic impact, for papers by S Matthes Breakdown of academic impact, for papers by A. Wischnik Breakdown of academic impact, for papers by Christian Focan Breakdown of academic impact, for papers by Chris A. Rhoades Breakdown of academic impact, for papers by Mark Peter
Rankless by CCL
2026